Anti-parathyroid Agents Market
Number of pages: 100 | Report Format: PDF | Published date: May 08, 2023
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023-2031
|
Report Attribute |
Details |
|
CAGR |
5.2% |
|
Base Year for Estimation |
2022 |
|
Forecast Period |
2023 to 2031 |
|
Historical Year |
2021 |
|
Segments Covered |
Drug Class, Distribution Channel, and Region |
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
According to the deep-dive market assessment study by Growth Plus Reports, the global anti-parathyroid agents market is expected to register a revenue CAGR of 5.2% during the forecast period from 2023 to 2031.
Anti-parathyroid Agents Market Fundamentals
Anti-parathyroid agents are a class of drugs used to treat parathyroid disorders, which are conditions that affect the parathyroid glands. The parathyroid glands are small glands located in the neck that produce parathyroid hormone (PTH). PTH helps regulate calcium and phosphorus levels in the body. Anti-parathyroid agents may be used alone or in combination with other drugs or therapies, depending on the specific condition being treated. Some common anti-parathyroid agents include Vitamin D analogues and calcium sensing receptor agonists.
There are two main types of parathyroid disorders, hyperparathyroidism, and hypoparathyroidism. Hyperparathyroidism occurs when the parathyroid glands produce too much PTH, leading to high calcium levels in the blood. Hypoparathyroidism occurs when the parathyroid glands produce too little PTH, leading to low calcium levels in the blood.
The global anti-parathyroid agents industry analysis report comprehensively analyzes the market, with the factors that either aid or impede the market growth, such as its drivers, restraints, and opportunities. The research provides insight into the companies that operate in the anti-parathyroid agents market and their efforts to position themselves as key players through expansion strategies and innovations. It also highlights recent developments that contribute to the anti-parathyroid agents market growth. The research also analyzes the impact of the COVID-19 pandemic.
This research is valuable for businesses seeking insights into the market, customers, and competition. The research provides special insights into the segmentation, regions, market size & projection, revenue CAGRs, and other important information that may help clients make the right decisions. The report assembles data from market players and professionals across the industrial value chain. The study also incorporates qualitative and quantitative assessments from industry professionals. Secondary research, surveys and interviews, and statistical modeling are all used in our research to estimate market size and projection. Our reports deliver the most reliable market data because of our specialized research methods.
Anti-parathyroid Agents Market Dynamics
The prevalence of parathyroid disorders such as hyperparathyroidism and hypoparathyroidism is increasing globally due to aging populations, changes in dietary habits, and lifestyle-related factors. As the prevalence of these disorders increases, the demand for anti-parathyroid agents is also expected to rise. Advances in drug delivery technologies, such as transdermal patches, intranasal delivery, and implantable devices, are also expected to drive growth in the anti-parathyroid agents market. These technologies offer advantages such as improved patient compliance, more targeted drug delivery, and reduced side effects. Rising healthcare expenditure, particularly in emerging economies, is expected to drive growth in the anti-parathyroid agents market. As more people gain access to healthcare services and insurance coverage, the demand for drugs to treat parathyroid disorders is expected to rise.
Additionally, the high cost of treatment, adverse effects, and lack of awareness and diagnosis are some of the restraints impeding the overall anti-parathyroid agents market growth.
Anti-parathyroid Agents Market Ecosystem
Anti-parathyroid Agents Market, by Drug Class
Anti-parathyroid Agents Market, by Distribution Channel
Anti-parathyroid Agents Market by Drug Class
[756755]
The vitamin D analogues segment dominated the market with the largest revenue share in 2022. Vitamin D analogues are a class of drugs used to treat parathyroid disorders, particularly those involving calcium and vitamin D metabolism disturbances. These analogues are synthetic compounds that are structurally similar to natural vitamin D but have different biological activities. Vitamin D analogues activate the vitamin D receptor in various tissues, including the parathyroid gland, which helps regulate the production of parathyroid hormone (PTH). In conditions such as primary hyperparathyroidism, where there is excessive production of PTH, vitamin D analogues can be used to suppress PTH levels and prevent complications such as osteoporosis and kidney stones. Some examples of vitamin D analogues used in treating parathyroid disorders include calcitriol, alfacalcidol, and paricalcitol.
The market segmentation sections provide the anti-parathyroid agents market outlook in terms of the demarcation of different consumer groups. Market segmentation is the split of an industry into subgroups depending on characteristics such as drug class, and distribution channel. Market segmentation data helps organizations understand the preferences and distinctive demands of different customer groups and implement targeted marketing strategies. This data additionally helps in identifying potential anti-parathyroid agents market demand opportunities.
Anti-parathyroid Agents Market by Region
North America dominated the global anti-parathyroid agents market with the largest revenue share in 2022 due to a high prevalence of parathyroid disorders, well-established healthcare infrastructure, and high healthcare spending levels. The market for anti-parathyroid agents in the United States is expected to grow due to an aging population and increasing awareness of parathyroid disorders. In addition, the United States is home to many leading pharmaceutical companies that develop and market anti-parathyroid agents.
Based on the regions, the global anti-parathyroid agents market is segmented into:
The industry's regional segmentation provides insights into geographic pockets in terms of anti-parathyroid agents industry trends, market size, share, and growth rate. This information helps organizations assess potential growth opportunities in new regional markets, understand competitive threats, and develop localized sales and expansion strategies. This section also offers deeper insights into the regional and country-level anti-parathyroid agents market overview.
Key Components of the Report
Anti-parathyroid Agents Market Competitive Landscape
The market competitive landscape analysis is performed by gathering and evaluating data about the key competitors, industry trends, and market dynamics. It involves collecting and analyzing data on factors such as products, pricing, geographic reach, customer demographics, marketing tactics, and recent developments. Competitive landscape analysis can help organizations identify present or prospective opportunities and risks in the market.
Anti-parathyroid Agents Market Strategic Developments
Reasons To Buy This Report
Key Strengths of Our Report
Target Audience to Benefit from this Report.
Anti-parathyroid agents are a class of drugs used to treat parathyroid disorders, which are conditions that affect the parathyroid glands.
Mergers, acquisitions, partnerships, and collaborations between companies are the major strategies adopted by key market players.
North American region will have the largest anti-parathyroid agents market size during the forecast period from 2023 to 2031.
The revenue CAGR of the anti-parathyroid agents market during the forecast period will be 5.2% from 2023 to 2031.
Increasing awareness and diagnosis is the most prominent anti-parathyroid agents industry trend.
The high cost of treatment, adverse effects, and lack of awareness and diagnosis are some key challenges hampering the growth of the global anti-parathyroid agents market.
Technological advancements and increasing healthcare expenditure are drivers for the global anti-parathyroid agents market.
Some of the prominent players in the anti-parathyroid agents market are Apotex Corporation, Jubilant Generics Limited, Aurobindo Pharma, OPKO Pharmaceuticals, LLC., Dr. Reddy's Laboratories, Inc., SANOFI COMPANY
The drug class segment has the highest share in the global anti-parathyroid agents market.
*Insights on financial performance are subject to the availability of information in the public domain